22 Dec 2023
PBAC Public Summary Documents – September 2023 meeting
PBAC Public Summary Documents – September 2023 meeting
22 Dec 2023
Update to Continued Dispensing Arrangements – Emergency Measures
From 22 December 2023 and to continue to 1 March 2024, a Continued Dispensing Emergency Measure has been put in place to temporarily support patients affected by the flooding disaster in Far North Queensland to continue to access their PBS subsidised medicines.
18 Dec 2023
Report on the Collection of Under Co-payment Data 2022-23
Report on the Collection of Under Co-payment Data 2022-23
15 Dec 2023
Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) – November 2023
Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) – November 2023
11 Dec 2023
PBS subsidy arrangements for fluoxetine SSSI
PBS subsidy arrangements for fluoxetine SSSI
08 Dec 2023
PBS reason codes 162/163 when dispensing biosimilar brands
PBS reason codes 162/163 when dispensing biosimilar brands
08 Dec 2023
Updates to the HTA Policy and Methods Review Reference Committee – 8 December 2023
Updates to the HTA Policy and Methods Review Reference Committee – 8 December 2023
01 Dec 2023
Updates to the HTA Policy and Methods Review Reference Committee – 1 December 2023
To ensure that the Reference Committee has sufficient time to consider the extensive and valuable input and material received for the HTA Review so far, as well as conduct further public consultation, the HTA Review has been extended until 15 April 2024.
01 Dec 2023
PBS Safety Net early supply for 60-day prescriptions
PBS Safety Net early supply for 60-day prescriptions